Influences of age and gender on dose response and time course of effect of atracurium in anesthetized adult patients.

[1]  A. Al-Ghamdi,et al.  Interactions between mivacurium and atracurium. , 1994, British journal of anaesthesia.

[2]  J. Hunter,et al.  Effect of age, sex and anaesthetic technique on the pharmacokinetics of atracurium. , 1992, British journal of anaesthesia.

[3]  O. Meretoja.  Neuromuscular Blocking Agents in Paediatric Patients: Influence of Age on the Response , 1990, Anaesthesia and intensive care.

[4]  T. Heier,et al.  Pharmacokinetics and pharmacodynamics of atracurium in the elderly. , 1990, Anesthesiology.

[5]  J. Hunter,et al.  Pharmacokinetics of atracurium and laudanosine in the elderly. , 1989, British journal of anaesthesia.

[6]  R. Matteo,et al.  Pharmacodynamics of Vecuronium and Atracurium in the Obese Surgical Patient , 1988, Anesthesia and analgesia.

[7]  F. Donati,et al.  Cumulative dose‐response with infusion: a technique to determine neuromuscular blocking potency of atracurium and vecuronium , 1988, Clinical pharmacology and therapeutics.

[8]  O. Meretoja,et al.  Infusion of atracurium in neonates, infants and children. A study of dose requirements. , 1988, British journal of anaesthesia.

[9]  D. Fisher.  Elimination of Atracurium in Humans , 1987 .

[10]  L B Sheiner,et al.  Elimination of Atracurium in Humans: Contribution of Hofmann Elimination and Ester Hydrolysis versus Organ‐based Elimination , 1986, Anesthesiology.

[11]  J. Dubernard,et al.  Atracurium in patients with renal failure. Clinical trial of a new neuromuscular blocker. , 1986, British journal of anaesthesia.

[12]  A. Abdel-Razek,et al.  Comparative Study on the Effect of Pancuronium and Atracurium in Normal Patients and Patients with Bilharzial Hepatic Fibrosis , 1986 .

[13]  G. Lavery,et al.  Comparison of cumulative and single bolus dose techniques for determining the potency of vecuronium. , 1985, British journal of anaesthesia.

[14]  P. Lilleaasen,et al.  Neuromuscular blocking effects of atracurium, vecuronium and pancuronium during bolus and infusion administration. , 1985, British journal of anaesthesia.

[15]  R. Miller,et al.  Neuromuscular Effects of Atracurlum during Halothane—Nitrous Oxide and Enflurane—Nitrous Oxide Anesthesia in Humans , 1985, Anesthesiology.

[16]  D. L. Schmucker.  Aging and drug disposition: an update. , 1985, Pharmacological reviews.

[17]  J. Hunter,et al.  Comparison of vecuronium, atracurium and tubocurarine in normal patients and in patients with no renal function. , 1984, British journal of anaesthesia.

[18]  D. R. Cook,et al.  Clinical Pharmacology of Atracurium in Infants , 1984, Anesthesia and analgesia.

[19]  J. Hunter,et al.  Atracurium in the myasthenic patient , 1983, Anaesthesia.

[20]  L. Barvais,et al.  Clinical evaluation of atracurium besylate requirement for a stable muscle relaxation during surgery: lack of age-related effects. , 1983, Anesthesiology.

[21]  M. Mehta,et al.  Safety and Efficacy of Atracurium (BW33A) in Surgical Patients Receiving Balanced or Isoflurane Anesthesia , 1983, Anesthesiology.

[22]  Neill Ea,et al.  Metabolism and kinetics of atracurium: an overview. , 1983 .

[23]  B. Walton,et al.  Use of atracurium infusions for general surgical procedures including cardiac surgery with induced hypothermia. , 1983, British journal of anaesthesia.

[24]  R. Miller,et al.  Neuromuscular and cardiovascular effects of atracurium during nitrous oxide-fentanyl and nitrous oxide-isoflurane anaesthesia. , 1983, British journal of anaesthesia.

[25]  D. R. Cook,et al.  Clinical pharmacology of atracurium in paediatric patients. , 1983, British journal of anaesthesia.

[26]  F. Foldes,et al.  Protein binding of atracurium and other short-acting neuromuscular blocking agents and their interaction with human cholinesterases. , 1983, British journal of anaesthesia.

[27]  R. Hughes,et al.  Interaction between atracurium and drugs used in anaesthesia. , 1983, British Journal of Anaesthesia.

[28]  H. Nagashima,et al.  Muscular relaxation with atracurium, vecuronium and duador under balanced anaesthesia. , 1983, British journal of anaesthesia.

[29]  R. Katz,et al.  Modification of atracurium blockade by halothane and by suxamethonium. A review of clinical experience. , 1983, British Journal of Anaesthesia.

[30]  R. Miller,et al.  Potency determination for vecuronium (ORG NC45): comparison of cumulative and single-dose techniques. , 1982, Anesthesiology.

[31]  R. Katz,et al.  Neuromuscular Effects of Atracurium in Man , 1982, Anesthesia and analgesia.

[32]  R. J. Saunders.  Anesthesia and the geriatric patient. , 1982, Otolaryngologic clinics of North America.

[33]  J. P. Payne,et al.  Evaluation of atracurium in anaesthetized man. , 1981, British journal of anaesthesia.

[34]  Bender Ad,et al.  Pharmacokinetic Consequences of Aging , 1977 .

[35]  H. H. Ali,et al.  A New Approach to the Study of Four Nondepolarizing Relaxants in Man , 1974, Anesthesia and analgesia.

[36]  B. Friis‐Hansen.  Body composition during growth. In vivo measurements and biochemical data correlated to differential anatomical growth. , 1971, Pediatrics.

[37]  D. Waud,et al.  On dose--response curves and anesthetics. , 1970, Anesthesiology.